- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01916044
Ultrasound Measure of the Thickness of the Lower Segment in Women Having a History of Caesarian
Evaluation of the Efficiency of the Ultrasound Measure of the Thickness of the Lower Segment Associated With a Rule of Decision to Reduce the Foetal and Maternal Morbidity and Mortality in the Care of the Deliveries of the Women Having a History of Caesarian: a Pragmatic Randomized Trial : Lustrial
The rate of caesarians dramatically increased for 15 years. The main indication of caesarian became the iterative caesarian of principle because of a history of caesarian. Any attempt of reduction of the rate of caesarians should thus focus on the indications of iterative principal caesarean. Nevertheless, the main reason usually evoked to justify a reduction of the attempts of low way after caesarian is the concern generated by the risk of uterine break during the trial of labor. Yet, there is no reliable method to predict this risk of uterine break. A way of interesting research consists in estimating the potential profits of the echography of the scar lower segment. Indeed, the echography can be useful to determine the specific risk of uterine break of a patient by measuring the thickness of the lower segment of the womb.
The strong negative predictive value of the echography of the lower segment on the risk of uterine break should encourage the women encircled to accept a trial of labor. That is why, this examination associated with a rule of decision could help to decrease the rate of iterative elective caesarians and especially to decrease the mortality and the foetal and maternal morbidity connected to the trial of labor among the patients having a history of caesarian.
Study Overview
Detailed Description
"Lower Uterine Segment Trial (LUSTrial)" Evaluation of the efficiency of the ultrasound measure of the thickness of the lower segment associated with a rule of decision to reduce the foetal and maternal morbidity and mortality in the coverage of the deliveries of the women having a history of caesarian: a pragmatic randomized trial
Aim Evaluation of the efficiency of the ultrasound measure of the thickness of the lower segment associated with a rule of decision to reduce the foetal and maternal morbidity and mortality in the coverage of the deliveries of the women having a history of caesarian Methodology Randomized trial, multicentric, open, in two parallel arms.
Evaluated treatments:
Between 36+0 and 38+6 weeks of amenorrhea, the patients will be invited to participate in the study. After agreement, the patients respecting the criteria of inclusion and not inclusion will be randomized in two groups:
GROUP A (experimental group) : The ultra sound measure of the thickness of the lower segment will be realized in a way standardized by expert sonographers. The patient will be informed that in case of measure:
- superior at the threshold of 3.5 mm, her will be considered " a low risk " by complications and will be encouraged to try a event of the work
- subordinate or equal at the threshold of 3.5 mm, her will be considered " at risk " by complications and will be encouraged to give birth by iterative elective caesarian.
GROUP B (control group) : The ultra sound measure of the lower segment will not be realized. The mode of delivery will be decided according to the current clinical practice.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Poissy, France
- CHI Poissy Saint Germain
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age ≥ 18 years
- unique pregnancy
- gestational age between 36 SA and 38SA +6 days
- cephalic presentation
- lower uterine segment section's history
- sign consent
Exclusion Criteria:
- age < 18 years
- history of longitudinal incision's caesarean
- iterative caesarean indication
- multiple pregnancy
- placenta praevia
- patient refuse trial of labor
- absent consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lower Uterine Segment Ultrasound
Measure of Uterine Segment by Ultrasound
|
Measure of Uterine Segment by Ultrasound
|
|
No Intervention: control
no measure of Uterine Segment Ultrasound
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite criterion including maternal and neonatal parameters
Time Frame: at 3 days post partum
|
rupture uterine, uterine dehiscence, hysterectomy, deep venous thromboembolic complications, transfusion, endometritis, maternal mortality, foetal mortality antepartum, intrapartum foetal mortality, ischemic hypoxic encephalopathy, neonatal mortality
|
at 3 days post partum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Uterine rupture
Time Frame: at 3 days post partum
|
at 3 days post partum
|
|
|
Uterine dehiscence
Time Frame: at 3 days post partum
|
Maternal morbidity
|
at 3 days post partum
|
|
Antepartum and intrapartum mortality
Time Frame: 3 days post partum
|
Foetal mortality
|
3 days post partum
|
|
Hypoxic-ischemic encephalopathy
Time Frame: at 3 days post partum
|
New born morbidity
|
at 3 days post partum
|
|
Thromboembolic complications
Time Frame: at 3 days post partum
|
Maternal morbidity
|
at 3 days post partum
|
|
Hysterectomy
Time Frame: at 3 days post partum
|
Maternal morbidity
|
at 3 days post partum
|
|
Transfusion
Time Frame: at 3 days post partum
|
Maternal morbidity
|
at 3 days post partum
|
|
Endometritis
Time Frame: at 3 days post partum
|
Maternal morbidity
|
at 3 days post partum
|
|
Rate of elective caesarean sections and of caesarean sections during labor
Time Frame: at 1 day post partum
|
at 1 day post partum
|
|
|
Perineal tears of the 3rd and 4th degree
Time Frame: at 1 day post partum
|
at 1 day post partum
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Patrick Rozenberg, MD, PhD, Chi Poissy
Publications and helpful links
General Publications
- Rozenberg P, Deruelle P, Senat MV, Desbriere R, Winer N, Simon E, Ville Y, Kayem G, Boutron I; Groupe de recherche en obstetrique et gynecologie. [Lower Uterine Segment Trial: A pragmatic open multicenter randomized trial]. Gynecol Obstet Fertil Senol. 2018 Apr;46(4):427-432. doi: 10.1016/j.gofs.2018.03.005. Epub 2018 Apr 4. French.
- Rozenberg P, Senat MV, Deruelle P, Winer N, Simon E, Ville Y, Kayem G, Porcher R, Perrodeau E, Desbriere R, Boutron I; Groupe de Recherche en Obstetrique et Gynecologie. Evaluation of the usefulness of ultrasound measurement of the lower uterine segment before delivery of women with a prior cesarean delivery: a randomized trial. Am J Obstet Gynecol. 2022 Feb;226(2):253.e1-253.e9. doi: 10.1016/j.ajog.2021.08.005. Epub 2021 Aug 9.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P111103
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor
-
Arrowhead Regional Medical CenterCompletedLabor | Labor Complication | Labor Delivery | Labor Dystocia | Uterine Contraction | Labor Active Dilated Cm | Labor DurationUnited States
-
University Hospital, GenevaQIAGEN Gaithersburg, Inc; Hologic, Inc.; Pregnolia ACCompletedLabor Onset | Labor, Induced | Labor, Obstetric | Predictive ModelSwitzerland
-
MemorialCare Health SystemCompletedLength of Labor | Second Stage of Labor | Intravenous Hydration of LaborUnited States
-
Raed SalimCompleted
-
HaEmek Medical Center, IsraelCompleted
-
University of California, San FranciscoRecruitingPregnancy | Labor Analgesia | Labor and DeliveryUnited States
-
CAMC Health SystemCompleted
-
University of RochesterJuniper Pharmaceuticals, Inc.WithdrawnLabor, PrematureUnited States
-
Hillel Yaffe Medical CenterNot yet recruitingPregnancy | Labor | Second Stage of Labor
-
Centre Hospitalier Universitaire de NīmesTerminatedObstetric Labor, Premature | Obstetric Labor | Labor OnsetFrance
Clinical Trials on Ultrasound
-
Ahram Canadian UniversityCompletedCarpal Tunnel Syndrome | Median Neuropathy, Carpal TunnelEgypt
-
Eskisehir Osmangazi UniversityCompletedCarpal Tunnel Syndrome
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Cairo UniversityUnknown
-
Ohio State University Comprehensive Cancer CenterWithdrawn
-
Oregon Health and Science UniversityRecruiting
-
Yale UniversityCompletedPneumonia | Pulmonary Edema | DyspneaUnited States
-
Odense University HospitalEnrolling by invitationThoracic Ultrasound | Fibrosing Interstitial Lung DiseasesDenmark
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedShoulder Impingement Syndrome | Shoulder PainTurkey
-
John PelleritoGeneral ElectricActive, not recruiting